EGFR Good Practice from the Patient’s Perspective
The purpose of the Good Practice guide is to empower patients to be involved in and informed about their treatment. It is intended for use by patients diagnosed with EGFR mutation positive Non-Small Cell Lung Cancer (NSCLC), the majority of whom will have been diagnosed at Stage 4. We have drawn heavily on the European Cancer Organisation’s Code of Cancer Practice.
Views expressed in the Good Practice guide are those of the charity and reflect the good practice that our members have experienced at the hands of leading thoracic medical oncologists.
Click here to read the guide.
